Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32566| Title: | COVID-19 living evidence profile #1 (version 1): What is known about anticipated COVID-19 vaccine roll-out elements? |
| Authors: | Wilson, MG DeMaio, P Wang, Q Gauvin, François-Pierre Alam, S Ahmad, A Bain, T Bhuiya, AR Drakos, A Sharma, K Whitelaw, S Lavis, JN |
| Keywords: | COVID-19;vaccine;roll-out |
| Publication Date: | Jan-2021 |
| Citation: | Wilson MG, DeMaio P, Wang Q, Gauvin FP, Alam S, Ahmad A, Bain T, Bhuiya A, Drakos A, Sharma K, Whitelaw S, Lavis JN. COVID-19 living evidence profile #1 (version 1): What is known about anticipated COVID-19 vaccine roll-out elements? Hamilton: McMaster Health Forum, 20 January 2021. |
| Series/Report no.: | LEP 1.1; |
| Abstract: | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and, if applicable, a scan of experiences from other countries and from Canadian provinces and territories, about anticipated COVID-19 vaccine roll-out elements in response to a decision-maker’s request. |
| URI: | http://hdl.handle.net/11375/32566 |
| Appears in Collections: | Living evidence profile |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| COVID-19 living evidence profile 1.1_What is known about anticipated COVID-19 vaccine roll-out elements (1).pdf | 520.49 kB | Adobe PDF | View/Open | |
| COVID-19 living evidence profile 1.1-appendix_What is known about anticipated COVID-19 vaccine roll-out elements (1).pdf | 1.6 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
